Panacea Biotec Limited — Board Meeting, 11-02-2026: Outcome of Board Meeting
11-02-2026 | 07:52 pm
11-02-2026 | 07:52 pm
Panacea Biotec's board approved Q3 FY26 consolidated results. Total income from operations stood at ₹165.19 Cr. The company reported a net profit of ₹3.89 Cr for the quarter, with EPS at ₹0.65.
No comments yet. Be the first to comment!
